#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital generalised lipodystrophy Epstein-Barr virus infection Dementia with Lewy bodies Ocular myasthenia Fungal infection Gestational trophoblastic tumour Acute graft versus host disease in liver Subarachnoid haemorrhage Glycogen storage disease type V Small cell lung cancer limited stage Thalassaemia Follicular lymphoma stage II Urea cycle disorder Myxofibrosarcoma Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Life with Disease MELAS syndrome Hereditary optic atrophy – Life with Disease Medulloblastoma Congenital nephrogenic diabetes insipidus Pemphigoid – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Pemphigus Myelodysplastic syndrome with excess blasts – Diagnostics Chondrosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vsf1.01 Amitriptyline Dabrafenib Triptorelin Molgramostim Taminadenant Setanaxib Elraglusib Dazodalibep Garetosmab Patiromer Oritavancin Water For Injection Sulfamethoxazole MAGNESIUM ACETATE TETRAHYDRATE L-Threonine Amisulpride Thiamine Nitrate Pentixather Vanzacaftor More therapies…

    Learn about Your Condition

    Skin neoplasm excision Oedema Post procedural swelling Small intestine adenocarcinoma Inclusion body myositis Ebola disease Inflammation Aortic disorder Dyspnoea PIK3CA-activated mutation Retinopathy of prematurity Tumour thrombosis Immunodeficiency Upper limb fracture C3 glomerulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital cystic kidney disease

  • A study to evaluate the effectiveness and safety of ursodeoxycholic acid in patients with hepatorenal polycystic diseases.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Polycystic liver disease
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Ursodeoxycholic Acid
    Spain

  • Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Austria Germany The Netherlands Spain

  • Study on Chronic Kidney Disease and Polycystic Kidney Disease Using Pyruvic Acid and MRI for Patients with These Conditions

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study Comparing Metformin and Tolvaptan for Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Tolvaptan
    • Metformin
    Italy

  • Study on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Rotigotine
    France

  • Study on the Safety and Effects of Tolvaptan for Children with Autosomal Recessive Polycystic Kidney Disease (ARPKD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Tolvaptan
    Belgium Germany Poland Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!